Recalls & Warnings November 29, 2012 Sensa Settles Second False Advertising Lawsuit On November 27, 2012, Sensa Products LLC, maker of the Sensa Weight Loss System, announced it agreed to settle a false advertising lawsuit filed by the Nutritional Supplemental Task Force in California, without an admission of guilt
Note: The FDA and USP require compound pharmacies to recommend multi dose vials only be used for 28 days unless they state the vial can last longer after testing
Development of a TaqMan assay for the six major genotypes of hepatitis C virus: comparison with commercial assays
Composition and Quality Validation of the Peptide Matrix To support rigorous, repeatable analytical trials, each constituent peptide in the blend is synthesized to exact structural specifications before integration: Mod GRF (Modified GRF 1-29 / CJC-1295 No DAC): A 29-amino-acid tetrasubstituted peptide analog optimized for structural stability against rapid blood plasma dipeptidyl peptidase-4 (DPP-4) cleavage
Hims & Hers portrays obesity with images of large, headless abdomens, which does create a visceral negative response by the viewer, Dr